1. Rao, PS, Ojo, A. Organ retransplantation in the United States: trends and implications. Clinical and Transplantation 2008; 57–67.
2. Freitas, MC. Kidney transplantation in the US: an analysis of the OPTN/UNOS registry. Clinical and Transplantation 2011; 1–16.
3. Cooper, DK, Novitzky, D, Wicomb, WN. The pathophysiological effects of brain death on potential donor organs, with particular reference to the heart. Annals of the Royal College of Surgeons of England 1989; 71: 261–266.
4. Novitzky, D, Cooper, DK, Reichart, B. Hemodynamic and metabolic responses to hormonal therapy in brain-dead potential organ donors. Transplantation 1987; 43: 852–854.
5. Nijboer, WN, et al. Effects of brain death on stress and inflammatory response in the human donor kidney. Transplantation Proceedings 2005; 37: 367–369.
6. Bouma, HR, Ploeg, RJ, Schuurs, TA. Signal transduction pathways involved in brain death-induced renal injury. American Journal of Transplantation 2009; 9: 989–997.
7. lznerowicz, A, et al. Duration of brain death and cold ischemia time, but not warm ischemia time, increases expression of genes associated with apoptosis in transplanted kidneys from deceased donors. Transplantation Proceedings 2011; 43: 2887–2890.
8. Kusaka, M, et al. Activation of inflammatory mediators in rat renal isografts by donor brain death. Transplantation 2000; 69: 405–410.
9. Olinga, P, et al. The influence of brain death on liver function. Liver International 2005; 25: 109–116.
10. Dziodzio, T, Biebl, M, Pratschke, J. Impact of brain death on ischemia/reperfusion injury in liver transplantation. Current Opinion in Organ Transplantation 2014; 19: 108–114.
11. Wilhelm, MJ, et al. Activation of the heart by donor brain death accelerates acute rejection after transplantation. Circulation 2000; 102: 2426–2433.
12. Weiss, S, et al. Brain death activates donor organs and is associated with a worse I/R injury after liver transplantation. American Journal of Transplantation 2007; 7: 1584–1593.
13. Pratschke, J, et al. Accelerated rejection of renal allografts from brain-dead donors. Annals of Surgeons 2000; 232: 263–271.
14. Leithead, JA, et al. Hepatic ischemia reperfusion injury is associated with acute kidney injury following donation after brain death liver transplantation. Transplant International 2013; 26: 1116–1125.
15. Damman, J, et al. Targeting complement activation in brain-dead donors improves renal function after transplantation. Transplant Immunology 2011; 24: 233–237.
16. Damman, J, et al. Systemic complement activation in deceased donors is associated with acute rejection after renal transplantation in the recipient. Transplantation 2011; 92: 163–169.
17. Hauser, P, et al. Genome-wide gene-expression patterns of donor kidney biopsies distinguish primary allograft function. Laboratory Investigation 2004; 84: 353–361.
18. McLean, KM, et al. Glucocorticoids alter the balance between pro- and anti-inflammatory mediators in the myocardium in a porcine model of brain death. Journal of Heart and Lung Transplantation 2007; 26: 78–84.
19. Bergler, T, et al. Infiltration of macrophages correlates with severity of allograft rejection and outcome in human kidney transplantation. PLoS One 2016; 11: e0156900.
20. Braza, F, et al. Role of TLRs and DAMPs in allograft inflammation and transplant outcomes. Nature Reviews Nephrology 2016; 12: 281–290.
21. Nagata, Y, et al. Anti-TNF-alpha agent infliximab and splenectomy are protective against renal ischemia-reperfusion injury. Transplantation 2016; 100: 1675–1682.
22. Wang, D, et al. Brief exercises affect gene expression in circulating monocytes. Scandinavian Journal of Immunology 2015; 82: 429–435.
23. Wu, D, et al. Network analysis reveals roles of inflammatory factors in different phenotypes of kidney transplant patients. Journal of Theoretical Biology 2014; 362: 62–68.
24. Heemann, UW, et al. Adhesion molecules and transplantation. Annals of Surgery 1994; 219: 4–12.
25. Venner, JM, et al. The molecular landscape of antibody-mediated kidney transplant rejection: evidence for NK involvement through CD16a Fc receptors. American Journal of Transplantation 2015; 15: 1336–1348.
26. Shang, D, et al. Profiling of mRNA and long non-coding RNA of urothelial cancer in recipients after renal transplantation. Tumour Biology 2016; 37: 12673–12684.
27. Baek, A, Cho, SR, Kim, SH. Elucidation of gene expression patterns in the brain after spinal cord injury. Cell Transplantation 2017; 26: 1286–1300.
28. Israni, AK, et al. Association of donor inflammation- and apoptosis-related genotypes and delayed allograft function after kidney transplantation. American Journal of Kidney Diseases 2008; 52: 331–339.
29. Alakulppi, NS, et al. Cytokine gene polymorphisms and risks of acute rejection and delayed graft function after kidney transplantation. Transplantation 2004; 78: 1422–1428.
30. Park, JY, et al. TNF-alpha and TGF-beta1 gene polymorphisms and renal allograft rejection in Koreans. Tissue Antigens 2004; 64: 660–666.
31. Goncalves-Primo, A, et al. Investigation of apoptosis-related gene expression levels in preimplantation biopsies as predictors of delayed kidney graft function. Transplantation 2014; 97: 1260–1265.
32. Kaminska, D, et al. Kidney ischemic injury genes expressed after donor brain death are predictive for the outcome of kidney transplantation. Transplantation Proceedings 2011; 43: 2891–2894.
33. Seok, J, et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proceedings of National Academy of Sciences of the United States of America 2013; 110: 3507–3512.
34. Freeman, TC, et al. A gene expression atlas of the domestic pig. BMC Biology 2012; 10: 90.
35. Barklin, A, et al. Does brain death induce a pro-inflammatory response at the organ level in a porcine model? Acta Anaesthesiologica Scandinavica 2008; 52: 621–627.
36. Skrabal, CA, et al. Organ-specific regulation of pro-inflammatory molecules in heart, lung, and kidney following brain death. Journal of Surgical Research 2005; 123: 118–125.
37. Stiegler, P, et al. Oxidative stress and apoptosis in a pig model of brain death (BD) and living donation (LD). Journal of Translational Medicine 2013; 11: 244.
38. Pratschke, J, et al. Influence of donor brain death on chronic rejection of renal transplants in rats. Journal of the American Society of Nephrology 2001; 12: 2474–2481.
39. Kusaka, M, et al. Up-regulation of osteopontin, chemokines, adhesion molecule, and heat shock proteins in 1-hour biopsy from cardiac death donor kidneys. Transplantation Proceedings 2006; 38: 3347–3350.
40. Connolly, GM, et al. Elevated soluble cellular adhesion molecules are associated with increased mortality in a prospective cohort of renal transplant recipients. BMC Nephrology 2011; 12: 23.
41. Spindler, RS, et al. N-Octanoyl dopamine for donor treatment in a brain-death model of kidney and heart transplantation. Transplantation 2015; 99: 935–941.
42. Krichen, H, et al. Toll-like receptor 4 and CD14 gene polymorphisms in Tunisian kidney transplantation. Transplantation Proceedings 2013; 45: 3472–3477.
43. Zhao, H, et al. Role of toll-like receptor-4 in renal graft ischemia-reperfusion injury. American Journal of Physiology-Renal Physiology 2014; 306: F801–F811.
44. Chen, X, et al. Cytokine and human leukocyte antigen (HLA) profile for graft-versus-host disease (GVHD) after organ transplantation. European Journal of Medical Research 2016; 21: 38.
45. Kohei, N, et al. Natural killer cells play a critical role in mediating inflammation and graft failure during antibody-mediated rejection of kidney allografts. Kidney International 2016; 89: 1293–1306.
46. Baan, CC, et al. Targeting JAK/STAT signaling to prevent rejection after kidney transplantation: a reappraisal. Transplantation 2016; 100: 1833–1839.
47. Kiss, E, et al. Peroxisome proliferator-activated receptor (PPAR)gamma can inhibit chronic renal allograft damage. American Journal of Pathology 2010; 176: 2150–2162.
48. Stahel, PF, et al. Experimental closed head injury: analysis of neurological outcome, blood-brain barrier dysfunction, intracranial neutrophil infiltration, and neuronal cell death in mice deficient in genes for pro-inflammatory cytokines. Journal of Cerebral Blood Flow & Metabolism 2000; 20: 369–380.
49. Fluiter, K, et al. Inhibition of the membrane attack complex of the complement system reduces secondary neuroaxonal loss and promotes neurologic recovery after traumatic brain injury in mice. Journal of Immunology 2014; 192: 2339–2348.
50. Muruve, NA, et al. Effect of donor brain-death duration on graft outcome. Transplantation Proceedings 2001; 33: 2980–2981.
51. Blasco, V, et al. Impact of intensive care on renal function before graft harvest: results of a monocentric study. Critical Care 2007; 11: R103.
52. Nijboer, WN, et al. How important is the duration of the brain death period for the outcome in kidney transplantation? Transplant International 2011; 24: 14–20.